{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:31:33Z","timestamp":1759624293804,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":547,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.exphem.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:52:34Z","timestamp":1693788754000},"page":"52-58.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6821-7033","authenticated-orcid":false,"given":"Anna","family":"Kopinska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Krawczyk-Kulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Wieczorkiewicz-Kabut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Koclega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Jagoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Dziaczkowska-Suszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2023.08.007_bib0001","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2023.08.007_bib0002","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0003","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2023.08.007_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hon.2267","article-title":"The importance of the number of transplanted cells with dipeptidyl peptidase-4 expression on the haematopoietic recovery and lymphocyte reconstitution in patients with multiple myeloma after autologous haematopoietic stem-cell transplantation","volume":"35","author":"Kopinska","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2023.08.007_bib0006","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0007","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0008","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdp342","article-title":"CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment","volume":"21","author":"Prabhash","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0009","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/nm.2991","article-title":"Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis","volume":"18","author":"Broxmeyer","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2023.08.007_bib0010","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","article-title":"The chemokine receptor CXCR4 in cell proliferation and tissue regeneration","volume":"11","author":"Bianchi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0011","first-page":"1345","article-title":"CD26\/dipeptidyl peptidase IV and its role in cancer","volume":"19","author":"Pro","year":"2004","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0012","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0168-8278(97)80180-8","article-title":"Aberrant dipeptidyl peptidase IV (DPP IV\/CD26) expression in human hepatocellular carcinoma","volume":"27","author":"Stecca","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.167.1.197","article-title":"Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation","volume":"167","author":"Houghton","year":"1988","journal-title":"J Exp. Med."},{"key":"10.1016\/j.exphem.2023.08.007_bib0014","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2559.1993.tb01199.x","article-title":"Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma","volume":"23","author":"Asada","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.exphem.2023.08.007_bib0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.08.007_bib0016","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bbmt.2008.04.013","article-title":"Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study","volume":"14","author":"Porrata","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.08.007_bib0017","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2257.1999.00253.x","article-title":"Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology","volume":"21","author":"Barnett","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0019","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood-2003-01-0073","article-title":"Transplantation for multiple myeloma: who, when, how often?","volume":"102","author":"Blad\u00e9","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.08.007_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-019-0205-9","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Al Hamed","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2023.08.007_bib0021","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.bbmt.2015.09.016","volume":"21","author":"Giralt","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.08.007_bib0022","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/bloodadvances.2019000524","article-title":"Long-term outcomes after autologous stem cell transplantation for multiple myeloma","volume":"4","author":"Nishimura","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2023.08.007_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41408-020-0273-x","article-title":"Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma","volume":"10","author":"Dimopoulos","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2023.08.007_bib0024","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1182\/blood-2002-12-3893","article-title":"Cell surface peptidase CD26\/DPPIV mediates G-CSF mobilization of mouse progenitor cells","volume":"101","author":"Christopherson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.08.007_bib0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0301-472X(03)00256-X","article-title":"CD26 is essential for normal G-CSF\u2013induced progenitor cell mobilization as determined by CD26\u2212\/\u2212 mice","volume":"31","author":"Christopherson","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0026","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.exphem.2010.12.003","article-title":"Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-\/\u2212 mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis","volume":"39","author":"Paganessi","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2023.08.007_bib0027","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1537-2995.2012.03826.x","article-title":"Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency","volume":"53","author":"Yoo","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2023.08.007_bib0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hemonc.2017.01.002","article-title":"CXCR4 (CD184) expression on stem cell harvest and CD34+ cells post-transplant","volume":"10","author":"Asfour","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.exphem.2023.08.007_bib0029","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1704355","article-title":"Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma","volume":"33","author":"Porrata","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.08.007_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbmt.2007.08.051","article-title":"Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"14","author":"Hiwase","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.08.007_bib0031","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbmt.2014.03.007","article-title":"Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma","volume":"20","author":"Rueff","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.08.007_bib0032","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V88.3.1089.1089","article-title":"Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery","volume":"88","author":"Kook","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.08.007_bib0033","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1700626","article-title":"Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow","volume":"19","author":"Talmadge","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.08.007_bib0034","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/trf.16424","article-title":"Autograft cellular composition and outcome in myeloma patients: results of the prospective multicenter GOA study","volume":"61","author":"Turunen","year":"2021","journal-title":"Transfusion"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23016752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23016752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:38:31Z","timestamp":1759567111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X23016752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"alternative-id":["S0301472X23016752"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2023.08.007","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of ISEH \u2013 Society for Hematology and Stem Cells.","name":"copyright","label":"Copyright"}]}}